|
|
Post by madog365 on Mar 21, 2017 11:03:19 GMT -5
Going to paraphrase from the Q4 earnings presentation some of the key initiatives that Mike laid out: - On the size of the salesforce: "approximately 3X of where we were last year in terms of where we expect to make impact. And we still have few more openings, I think, six or seven."
- On nurse educators: "We transition to a per day nurse educator model. And so now we have almost 80 nurse educators across the country who will help to a per day in training and/or education in office"
- On reality show sponsorship: "we’ve partnered with third-party, such as Charles Mattocks who’s putting a reality show on for diabetes on this Discovery Life in the summer. That will be one of the first time you will see our TV commercial aired. It’s part of our sponsorship. We are going to get exclusive commercials during that show."
- On Damon Dash: "He has genuinely taken an interest in the product and with diabetes and educating others around their diabetes health. He’ll be launching something called Dash diabetes network over the coming weeks and there will be targeted content launching out of that process"
- On in-doctor's office ads: I wanted to announce today the Outcome Health platform...You’ve got the TV in the doctor’s office....You have the billboard if you look on the left wall, there’s like electronic billboards that will rotate, and you have patient iPads in the office. So when you’re waiting for the doctor to come in, you have an iPad and in all those scenarios you will see a Afrezza branding and ads being placed. They have averaged over 155,000 doctors, obviously, we won’t be in all those offices. But we will be in a large percentage of our targets that have this capacity and capability in the office.
- On social media: We’ll be partnering with a leading third-party portal who works with patients and doctors. They have 6 million people with diabetes in their network, 2.2 million unique visitors a month to the properties, and all 30,000 of our targets for doctors who will be also being engaged
Lot's of exciting developments - will they finally get the word out? |
|
|
|
Post by dreamboatcruise on Mar 21, 2017 11:15:54 GMT -5
It's interesting that on the salesforce, he made the case that qualitatively there is going to be big improvement based on hiring full time employees rather than contract reps... and yet it seems they are at the same time doing exactly the opposite for the nurse educators.
I do particularly like that one of these initiatives has "over the coming weeks" attached to it. Seeing the results of the plans will be exciting.
|
|
|
|
Post by mnholdem on Mar 21, 2017 11:30:41 GMT -5
Patient Web Portals to Improve Diabetes Outcomes: A Systematic Review
Excerpt:
Abstract
Patient web portals (PWPs), defined as the integration of electronic medical records and patient health records, have been related to enhanced patient outcomes. A literature review was conducted to characterize the design and evaluation of PWPs to improve health care processes and outcomes in diabetes. A summary of 26 articles revealed the positive impact PWPs have on patient outcomes, patient-provider communication, disease management, and access to and patient satisfaction with health care.
Source: www.ncbi.nlm.nih.gov/pmc/articles/PMC3086814/
---
We have a few diggers on this board. What portal services company out there currently meets the statistics which Mike stated at the earning call?
"We’ll be partnering with a leading third-party portal who works with patients and doctors. They have 6 million people with diabetes in their network, 2.2 million unique visitors a month to the properties..."
|
|
|
|
Post by tw12 on Mar 21, 2017 11:53:37 GMT -5
Here's a 2015 article from HealthcareITnews, for starters: Patient Engagement 3 vendors best at driving patient portals KLAS names top 3 companies working to make patient engagement a slam-dunk By Bernie MonegainApril 23, 201510:21 AM Woman with laptop With a meaningful use requirement for healthcare organizations to drive at least 5 percent of their patients to an online portal, KLAS finds that three vendors have more than 20 percent of their customers' patients accessing the portal, a number that far surpasses the 5 percent meaningful use requisite. The three vendors KLAS deemed most effective at helping their clients drive patient portal adoption are: athenahealth, Epic and Medfusion.Many healthcare organizations have expressed anxiety concerning the patient portal mandate, saying they are concerned about being responsible for a mandate that relies on what other people (the patients) do. [See also: Patient portal mandate triggers anxiety.] As part of its research for the report "Patient Portals 2015: Adoption beyond Meaningful Use," KLAS interviewed 186 healthcare provider organizations to determine which vendors have proven to best meet current needs while also developing solutions for the future. The report analyzes three types of portals: enterprise, ambulatory and EMR agnostic. The focus of the report is to examine product performance, vendor guidance and other factors that impact providers' ability to achieve success with patient portal adoption, according to KLAS. "Value-based care is forcing patient portals to evolve from being merely tools for reactive regulatory compliance to becoming valuable instruments that allow patients to proactively engage in their own care," said report author Coray Tate, in a news release. "Providers report that vendor guidance and functionality that patients find useful, such as billing and self-scheduling, are the most effective ways to encourage portal adoption among patients." ---------- And this as well: www.healthcareitnews.com/news/livongo-nabs-52-million-expand-beyond-diabetes-other-chronic-conditions |
|
|
|
Post by compound26 on Mar 21, 2017 11:53:58 GMT -5
Patient Web Portals to Improve Diabetes Outcomes: A Systematic Review
Excerpt:
Abstract
Patient web portals (PWPs), defined as the integration of electronic medical records and patient health records, have been related to enhanced patient outcomes. A literature review was conducted to characterize the design and evaluation of PWPs to improve health care processes and outcomes in diabetes. A summary of 26 articles revealed the positive impact PWPs have on patient outcomes, patient-provider communication, disease management, and access to and patient satisfaction with health care.
Source: www.ncbi.nlm.nih.gov/pmc/articles/PMC3086814/
---
We have a few diggers on this board. What portal services company out there currently meets the statistics which Mike stated at the earning call?
"We’ll be partnering with a leading third-party portal who works with patients and doctors. They have 6 million people with diabetes in their network, 2.2 million unique visitors a month to the properties..."
I will give it a shot. It is likely： corp.inspire.com/See this report from 2010. They worked with Amgen before and at the time of the report, the site draws in over 1.4 million unique posts and 500,000 unique visitors monthly. Quote from the report: "Social networks can help companies mobilize patients by collaborating with medical foundations. Case study: Mobilized patients Example: Amgen worked with the National Osteoporosis Foundation (NOF) and Inspire’s patient communities to mobilize patients to lobby for access to early bone density screening (DXA) • Because Amgen was developing an osteoporosis treatment Denosumab, Amgen’s Government Affairs department needed to understand patient sentiment about Medicare DXA cuts and DXA access. Social networks and applications • Inspire is a diverse community of over 190 groups covering conditions such as oncology and osteoporosis. The site draws in over 1.4 million unique posts and 500,000 unique visitors monthly. Seventy of these groups collaborate with leading health organizations like the NOF, and are connected by conditions such as cancer, osteoporosis, and diabetes. • Amgen worked with the NOF and Inspire to develop a survey to understand patient sentiment. • The survey was sent out with disclosure of the sponsors and their purpose."
|
|
|
|
Post by mnholdem on Mar 21, 2017 14:47:30 GMT -5
It makes sense that former Amgen executives would hook up with a portal service company they are familiar with. Good investigative work!
|
|
|
|
Post by surplusvalue on Mar 21, 2017 23:11:19 GMT -5
Going to paraphrase from the Q4 earnings presentation some of the key initiatives that Mike laid out: - On the size of the salesforce: "approximately 3X of where we were last year in terms of where we expect to make impact. And we still have few more openings, I think, six or seven."
- On nurse educators: "We transition to a per day nurse educator model. And so now we have almost 80 nurse educators across the country who will help to a per day in training and/or education in office"
- On reality show sponsorship: "we’ve partnered with third-party, such as Charles Mattocks who’s putting a reality show on for diabetes on this Discovery Life in the summer. That will be one of the first time you will see our TV commercial aired. It’s part of our sponsorship. We are going to get exclusive commercials during that show."
- On Damon Dash: "He has genuinely taken an interest in the product and with diabetes and educating others around their diabetes health. He’ll be launching something called Dash diabetes network over the coming weeks and there will be targeted content launching out of that process"
- On in-doctor's office ads: I wanted to announce today the Outcome Health platform...You’ve got the TV in the doctor’s office....You have the billboard if you look on the left wall, there’s like electronic billboards that will rotate, and you have patient iPads in the office. So when you’re waiting for the doctor to come in, you have an iPad and in all those scenarios you will see a Afrezza branding and ads being placed. They have averaged over 155,000 doctors, obviously, we won’t be in all those offices. But we will be in a large percentage of our targets that have this capacity and capability in the office.
- On social media: We’ll be partnering with a leading third-party portal who works with patients and doctors. They have 6 million people with diabetes in their network, 2.2 million unique visitors a month to the properties, and all 30,000 of our targets for doctors who will be also being engaged
Lot's of exciting developments - will they finally get the word out?No doubt all important developments. Given that the Dash efforts are coming sometime in April? and the Mattocks/commercials not until July the other DTC efforts (in doctor office ads and social media) should have been ready to roll out with the new permanent sales force early this year to support the new sales team. It was clear that Sanofi did virtually no DTC and everyone saw the results.After burning 50 million and focusing almost exclusively again on the doctors with the contract sales force MNKD could already see the very limited sales results without DTC. Instead more of the same since January and almost three months later and another 30 million together with sales moving in the opposite direction. The new improved sales force up to now hasnt even done as well as the old sales team. This was just poor transitional planning and bad management decisions. Think about if they had had DTC in place earlier this year wouldnt there have been a greater potential to increase sales and perhaps bring the share price over $1 by March. The reverse realisticaly might not have been needed at all. Even aside from this why would you allow such a huge stagnation in sales when you could at least have tried with DTC to fill the gap left by the transition? For a company that keeps saying it wants to be careful with spending this has been a pretty expensive lesson; not to mention the recent 20% cut to the share price. Like I said before in another post even the dumbest kid on the side of the road selling lemonade knows you have to advertise. It cant come too soon. |
|
|
|
Post by slugworth008 on Mar 22, 2017 0:43:04 GMT -5
Going to paraphrase from the Q4 earnings presentation some of the key initiatives that Mike laid out: - On the size of the salesforce: "approximately 3X of where we were last year in terms of where we expect to make impact. And we still have few more openings, I think, six or seven."
- On nurse educators: "We transition to a per day nurse educator model. And so now we have almost 80 nurse educators across the country who will help to a per day in training and/or education in office"
- On reality show sponsorship: "we’ve partnered with third-party, such as Charles Mattocks who’s putting a reality show on for diabetes on this Discovery Life in the summer. That will be one of the first time you will see our TV commercial aired. It’s part of our sponsorship. We are going to get exclusive commercials during that show."
- On Damon Dash: "He has genuinely taken an interest in the product and with diabetes and educating others around their diabetes health. He’ll be launching something called Dash diabetes network over the coming weeks and there will be targeted content launching out of that process"
- On in-doctor's office ads: I wanted to announce today the Outcome Health platform...You’ve got the TV in the doctor’s office....You have the billboard if you look on the left wall, there’s like electronic billboards that will rotate, and you have patient iPads in the office. So when you’re waiting for the doctor to come in, you have an iPad and in all those scenarios you will see a Afrezza branding and ads being placed. They have averaged over 155,000 doctors, obviously, we won’t be in all those offices. But we will be in a large percentage of our targets that have this capacity and capability in the office.
- On social media: We’ll be partnering with a leading third-party portal who works with patients and doctors. They have 6 million people with diabetes in their network, 2.2 million unique visitors a month to the properties, and all 30,000 of our targets for doctors who will be also being engaged
Lot's of exciting developments - will they finally get the word out?No doubt all important developments. Given that the Dash efforts are coming sometime in April? and the Mattocks/commercials not until July the other DTC efforts (in doctor office ads and social media) should have been ready to roll out with the new permanent sales force early this year to support the new sales team. It was clear that Sanofi did virtually no DTC and everyone saw the results.After burning 50 million and focusing almost exclusively again on the doctors with the contract sales force MNKD could already see the very limited sales results without DTC. Instead more of the same since January and almost three months later and another 30 million together with sales moving in the opposite direction. The new improved sales force up to now hasnt even done as well as the old sales team. This was just poor transitional planning and bad management decisions. Think about if they had had DTC in place earlier this year wouldnt there have been a greater potential to increase sales and perhaps bring the share price over $1 by March. The reverse realisticaly might not have been needed at all. Even aside from this why would you allow such a huge stagnation in sales when you could at least have tried with DTC to fill the gap left by the transition? For a company that keeps saying it wants to be careful with spending this has been a pretty expensive lesson; not to mention the recent 20% cut to the share price. Like I said before in another post even the dumbest kid on the side of the road selling lemonade knows you have to advertise. It cant come too soon. Ditto and ditto !! |
|
|
|
Post by sportsrancho on Mar 22, 2017 8:26:55 GMT -5
Here is a link to the commercials in the doctors offices. In reply to EMBED Mar. 22 at 5:45 AM Barnstormer Gary King @ia_0007 Would love to see it. Do you know who did the original post. Maybe they can post link Mar. 22 at 5:54 AM ia_0007 barnstormer IMG_7468.MOV.mov Bullish There is a picture on ST but I can't copy it. The link is working for some which shows the video. |
|
|
|
Post by madog365 on Mar 27, 2017 16:25:35 GMT -5
|
|
|
|
Post by madog365 on Mar 28, 2017 9:01:47 GMT -5
|
|
|
|
Post by peppy on Mar 28, 2017 9:23:25 GMT -5
This does not make sense. Quote " A hypoglycemic episode was
recorded if a patient reported symptoms of hypoglycemia with or
without a blood glucose value consistent with hypoglycemia."
Hypoglycemia
Hypoglycemia is the most commonly observed adverse reaction
in patients using insulin, including AFREZZA [see Warnings and
Precautions (5.3)]. The incidence of severe and non-severe
hypoglycemia of AFREZZA versus placebo in patients with type 2
diabetes is shown in Table 3. A hypoglycemic episode was
recorded if a patient reported symptoms of hypoglycemia with or
without a blood glucose value consistent with hypoglycemia. Severe
hypoglycemia was defined as an event with symptoms consistent
with hypoglycemia requiring the assistance of another person and
associated with either a blood glucose value consistent with
hypoglycemia or prompt recovery after treatment for hypoglycemia.
Table 3. Incidence of Severe and Non-Severe Hypoglycemia
in a Placebo-Controlled Study of Patients with Type 2
Diabetes
page 4 afrezza.com/wp-content/uploads/2016/08/afrezza.pdf
|
|
|
|
Post by agedhippie on Mar 28, 2017 10:31:04 GMT -5
This does not make sense. Quote " A hypoglycemic episode was
recorded if a patient reported symptoms of hypoglycemia with or
without a blood glucose value consistent with hypoglycemia." Clinical hypoglycemia starts around 70 but you can get the symptoms of hypoglycemia at higher levels if you have been running a high average. Your body adjusts where it thinks the threshold should be. It works the other way as well - if you have a lot of lows your body will set the threshold under where hypoglycemia starts. These are the symptoms though - hypoglycemia itself doesn't change. |
|
|
|
Post by surplusvalue on Mar 28, 2017 22:39:30 GMT -5
Going to paraphrase from the Q4 earnings presentation some of the key initiatives that Mike laid out: - On the size of the salesforce: "approximately 3X of where we were last year in terms of where we expect to make impact. And we still have few more openings, I think, six or seven."
- On nurse educators: "We transition to a per day nurse educator model. And so now we have almost 80 nurse educators across the country who will help to a per day in training and/or education in office"
- On reality show sponsorship: "we’ve partnered with third-party, such as Charles Mattocks who’s putting a reality show on for diabetes on this Discovery Life in the summer. That will be one of the first time you will see our TV commercial aired. It’s part of our sponsorship. We are going to get exclusive commercials during that show."
- On Damon Dash: "He has genuinely taken an interest in the product and with diabetes and educating others around their diabetes health. He’ll be launching something called Dash diabetes network over the coming weeks and there will be targeted content launching out of that process"
- On in-doctor's office ads: I wanted to announce today the Outcome Health platform...You’ve got the TV in the doctor’s office....You have the billboard if you look on the left wall, there’s like electronic billboards that will rotate, and you have patient iPads in the office. So when you’re waiting for the doctor to come in, you have an iPad and in all those scenarios you will see a Afrezza branding and ads being placed. They have averaged over 155,000 doctors, obviously, we won’t be in all those offices. But we will be in a large percentage of our targets that have this capacity and capability in the office.
- On social media: We’ll be partnering with a leading third-party portal who works with patients and doctors. They have 6 million people with diabetes in their network, 2.2 million unique visitors a month to the properties, and all 30,000 of our targets for doctors who will be also being engaged
Lot's of exciting developments - will they finally get the word out?No doubt all important developments. Given that the Dash efforts are coming sometime in April? and the Mattocks/commercials not until July the other DTC efforts (in doctor office ads and social media) should have been ready to roll out with the new permanent sales force early this year to support the new sales team. It was clear that Sanofi did virtually no DTC and everyone saw the results.After burning 50 million and focusing almost exclusively again on the doctors with the contract sales force MNKD could already see the very limited sales results without DTC. Instead more of the same since January and almost three months later and another 30 million together with sales moving in the opposite direction. The new improved sales force up to now hasnt even done as well as the old sales team. This was just poor transitional planning and bad management decisions. Think about if they had had DTC in place earlier this year wouldnt there have been a greater potential to increase sales and perhaps bring the share price over $1 by March. The reverse realisticaly might not have been needed at all. Even aside from this why would you allow such a huge stagnation in sales when you could at least have tried with DTC to fill the gap left by the transition? For a company that keeps saying it wants to be careful with spending this has been a pretty expensive lesson; not to mention the recent 20% cut to the share price. Like I said before in another post even the dumbest kid on the side of the road selling lemonade knows you have to advertise. It cant come too soon. Correction . Make that 35% cut to the share price post RS. Management has nothing and I indicated a long time ago that a RS without anything to support it is the kiss of death for previously existing shareholders (especially underwater ones.) Puts the idiocy that a RS is just a splitting of the pie into perspective now. Didnt fool anyone did it? And my criticism above still stands regarding the absence of advertising especially during the transition to a new sales team which might have made the RS unnecessary. Just horrible planning. Management is beyond inept. And for those of you who want the company to step in and defend itself and or buy shares you can forget it ; they have not done this before (starting at $11 and downwards) and are not about to start now. Even so its too late. Speaking of which, the new improved? sales team at double the size has managed an average of 242 scripts weekly since January while the previous contract sales team at half the size averaged about 275 scripts weekly from Sept to December. Can we get the old team back? All tolled management has burned more than 80 million dollars after getting the NDA back and this is the result. Experience should now tell you to forget about waiting for weekly script counts at this juncture; management has had more than 8 months to deliver and virtually nothing. A marginal increase and even double the scripts isnt going to do anything so all you cheerleaders can give it a rest. The company is on life support. They need to move product and a lot of it. All the problems are still here: pricing , coverage , titration, lack of awareness, no substantive advertising, retention, misinformation in the market, lack of information in the market, cash flow/finances , debt, etc , etc, etc. And the kicker is that all this throwing of tremendous amounts of money and resources at educating the doctors seem to have resulted in so few prescribers that when one prescriber dies (yes just one) the script count for the whole 4th quarter suffers according to management. Its really unbelievable how much of an absolute failure commercialization has been since they got the NDA back and the inability of management to re-evaluate what they are doing. In a number of decidedly important ways management has been dumber than a bag of hammers. And this is leaving alone the immeasurable impact of all the funds lost by shareholders. I just shake my head in disbelief. |
|
|
|
Post by fanz8967 on Mar 31, 2017 11:18:46 GMT -5
What are the scripts reported in? 1000's? 10,000's? These don't make any sense to me. AMRN had 23,000 last week and that was OK. So, if MNKD had 256,000 scripts, that seems pretty good. Why is everyone saying they are very bad scripts?
|
|
